Both the US FDA and Health Canada are working towards reducing trans fats from the food supply by banning the use of partially hydrogenated oils (PHOs). For companies with a wide range of products, this could prove to be difficult. However, if you are already using Genesis R&D, things will be a little simpler.
The FDA announced their intent to extend the compliance dates for Supplement and Nutrition Facts Labeling. At this time, the FDA has not commented on when the new enforcement dates will be nor have they published an official notice on the Federal Register.
We often receive questions regarding how ESHA implements recommendations for compliance from the FDA's Guidance for Industry documents into our software solutions. This blog briefly covers how we regard and use both types of guidance documents that the FDA publishes.